How To Use Endocrine Therapy In Premenopausal Women With Er+ Metastatic Breast Cancer

How to use endocrine therapy in premenopausal women with ER+ metastatic breast cancer

European Society for Medical Oncology (ESMO)

How to use endocrine therapy in premenopausal women with ER+ early breast cancer

European Society for Medical Oncology (ESMO)

Endocrine therapy in premenopausal women with HR+ breast cancer

Dr. Hershman on the Use of Endocrine Therapy in Premenopausal HR+/HER2- Breast Cancer

Evaluating endocrine therapy in pre-menopausal women with breast cancer

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Adjuvant Therapy of Breast Cancer

Dr. Cristofanilli on Endocrine Therapy for Breast Cancer

Treating Breast Cancer in Premenopausal Women

Targeted Oncology

Dr. Rao on the SOFT Trial in Patients With Premenopausal Breast Cancer

Endocrine manipulations in premenoupausal metastatic HER2 positive breast cancer: breaking the s...

Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Determining Endocrine Therapy for Premenopausal Breast Cancer Patients: Practical Considerations

Dr. Joseph Sparano on the Role of Endocrine Therapy in Breast Cancer

CDK4/6 Inhibitors & Endocrine Therapy in Breast Cancer

Targeted Oncology

Treating ER+ breast cancer patients with endocrine therapy resistance

Management of premenopausal HR+/HER2- breast cancer with micro-metastasis

Ovarian Suppression in Metastatic HR+ Breast Cancer

NCCN Animation for Patients: Overview of Endocrine Therapy for Metastatic Breast Cancer

NCCN

Treating Metastatic Breast Cancer

Living Beyond Breast Cancer